TherapeuticsMD

TXMD41

Penny Stock

$1.40arrow_drop_down4.10%-$0.06

Penny Stock

TXMD41

$1.40

arrow_drop_down4.10%-$0.06

Penny Stock

Performance History

Key Stats
Open	$1.46
Prev. Close	$1.46
EPS	-0.41
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$16.14M
PE Ratio	-

	LOW	HIGH
Day Range	1.37	1.47
52 Week Range	1.37	3.07

Ratios







EPS	-0.41

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About TherapeuticsMD (TXMD)

TherapeuticsMD Inc (TXMD) is a pharmaceutical company specializing in women's health. The company is focused on developing and commercializing innovative hormone therapy and prescription products. With a strong commitment to advancing women's health, TherapeuticsMD is dedicated to providing safe and effective treatment options for a variety of conditions. The company's stock price history shows fluctuations over the years, reflecting the volatility of the pharmaceutical industry. Investors should carefully analyze market trends and company performance before making any investment decisions.

As of the latest quote, TherapeuticsMD Inc (TXMD) is trading at $2.75 per share. This information is subject to change as market conditions fluctuate. Investors should keep an eye on the stock news and updates to stay informed of any significant developments that may impact the stock price. Market analysis of TherapeuticsMD Inc (TXMD) suggests that the stock has the potential for growth, but investors should conduct their own research and analysis to determine its suitability for their investment portfolio. The stock's PEG ratio can provide insights into its valuation relative to its growth prospects.

Websitecall_made

Sector: Healthcare
Industry: Drug Manufacturers—Specialty & Generic
CEO
Headquarters: Boca Raton
Employees: 1
Exchange: NASDAQ

Keep an eye on TherapeuticsMD

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the market capitalization of TherapeuticsMD (TXMD)?

TherapeuticsMD (TXMD) has a market capitalization of $16.15M. The average daily trading volume is 1.43, indicating the stock's liquidity and investor engagement.

help

What is TherapeuticsMD 's (TXMD) price per share?

The current price per share for TherapeuticsMD (TXMD) is $1.4. The stock has seen a price change of -$0.06 recently, indicating a -4.11% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for TherapeuticsMD (TXMD)?

For TherapeuticsMD (TXMD), the 52-week high is $3.07, which is 119.29% from the current price. The 52-week low is $1.37, the current price is 2.19% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is TherapeuticsMD (TXMD) a growth stock?

TherapeuticsMD (TXMD) has shown an average price growth of -6.65% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying TherapeuticsMD as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is TherapeuticsMD (TXMD) stock price performance year to date (YTD)?

As of the latest data, TherapeuticsMD (TXMD) has a year-to-date price change of -39.91%. Over the past month, the stock has experienced a price change of -11.39%. Over the last three months, the change has been -15.15%. Over the past six months, the figure is -36.94%. Looking at a longer horizon, the five-year price change stands at -98.94%.

help

Is TherapeuticsMD (TXMD) a profitable company?

TherapeuticsMD (TXMD) has a net income of -$10.28M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -157.04% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.3M, although specific revenue growth data is currently not available. The gross profit is $1.3M. Operating income is noted at -$8.52M. Furthermore, the EBITDA is -$4.54M.